Telix Pharmaceuticals Ltd (TLX) — SEC Filings
Telix Pharmaceuticals Ltd (TLX) — 5 SEC filings. Latest: 6-K (Apr 14, 2026). Includes 4 6-K, 1 3.
View Telix Pharmaceuticals Ltd on SEC EDGAR
Overview
Telix Pharmaceuticals Ltd (TLX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 14, 2026: Telix Pharmaceuticals Ltd filed a 6-K report on April 14, 2026. The filing includes various exhibits, such as EX-99.1 and EX-99.2, which likely contain important operational or financial updates. The company's mailing and business address are both located at 55 Flemington Road, North Melbourne, C3 3
Sentiment Summary
Across 5 filings, the sentiment breakdown is: 5 neutral. The dominant filing sentiment for Telix Pharmaceuticals Ltd is neutral.
Filing Type Overview
Telix Pharmaceuticals Ltd (TLX) has filed 1 3, 4 6-K with the SEC between Apr 2026.
Recent SEC Filings (5)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 14, 2026 | 6-K | Telix Pharmaceuticals Files 6-K Report | low |
| Apr 10, 2026 | 6-K | Telix Pharmaceuticals Files 6-K Report | low |
| Apr 9, 2026 | 6-K | 6-K Filing | |
| Apr 7, 2026 | 6-K | Telix Pharmaceuticals Files Q1 2026 Business Update | low |
| Apr 1, 2026 | 3 | 3 Filing |
Risk Profile
Risk Assessment: Of TLX's 3 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 3 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
foreign-issuer (2) · sec-filing (1) · regulatory-update (1) · regulatory-filing (1) · corporate-update (1) · quarterly-report (1) · business-update (1)
Frequently Asked Questions
What are the latest SEC filings for Telix Pharmaceuticals Ltd (TLX)?
Telix Pharmaceuticals Ltd has 5 recent SEC filings from Apr 2026, including 4 6-K, 1 3. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of TLX filings?
Across 5 filings, the sentiment breakdown is: 5 neutral. The dominant sentiment is neutral.
Where can I find Telix Pharmaceuticals Ltd SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Telix Pharmaceuticals Ltd (TLX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Telix Pharmaceuticals Ltd?
Financial highlights for Telix Pharmaceuticals Ltd are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for TLX?
Investment thesis data for TLX will be available once enriched filings are processed.
Who are the key executives at Telix Pharmaceuticals Ltd?
Executive information for Telix Pharmaceuticals Ltd is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Telix Pharmaceuticals Ltd stock?
Of TLX's 3 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Telix Pharmaceuticals Ltd?
Forward guidance and predictions for Telix Pharmaceuticals Ltd are extracted from SEC filings as they are enriched.